We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+22.84%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.3%
AUM
$1.59B
AUM Growth
-$22.5M
Cap. Flow
-$179M
Cap. Flow %
-11.29%
Top 10 Hldgs %
7.3%
Holding
2,269
New
605
Increased
523
Reduced
559
Closed
577

Sector Composition

Rank Sector Weight
1 Healthcare 15.05%
2 Financials 14.8%
3 Technology 14.7%
4 Industrials 13.56%
5 Consumer Discretionary 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHC icon
551
Encompass Health
EHC
$12B
$933K 0.06%
9,234
-30,025
-76% -$3.11M
AGIO icon
552
Agios Pharmaceuticals
AGIO
$1.96B
$932K 0.06%
25,113
-11,359
-31% -$345K
BLND icon
553
Blend Labs
BLND
$253M
$931K 0.06%
544,168
+101,075
+23% +$161K
CLOV icon
554
Clover Health Investments
CLOV
$2.4B
$931K 0.06%
177,633
-257,801
-59% -$875K
NX icon
555
Quanex
NX
$884M
$931K 0.06%
49,978
-8,645
-15% -$160K
KHC icon
556
The Kraft Heinz Company
KHC
$28.3B
$929K 0.06%
+39,323
New +$908K
RBB icon
557
RBB Bancorp
RBB
$447M
$928K 0.06%
33,854
+1,130
+3% +$27.1K
TRV icon
558
Travelers Companies
TRV
$75.6B
$928K 0.06%
+2,810
New +$852K
AEHR icon
559
Aehr Test Systems
AEHR
$3.18B
$926K 0.06%
9,639
-7,728
-44% -$706K
ABX
560
Abacus Global Management
ABX
$809M
$924K 0.06%
86,232
+43,952
+104% +$401K
FLR icon
561
Fluor
FLR
$6.77B
$921K 0.06%
+17,584
New +$861K
NUE icon
562
Nucor
NUE
$56.3B
$916K 0.06%
4,113
+1,597
+63% +$361K
DOCN icon
563
DigitalOcean
DOCN
$16.6B
$914K 0.06%
+5,819
New +$787K
XLY icon
564
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.6B
$914K 0.06%
7,795
+1,256
+19% +$147K
KODK icon
565
Kodak
KODK
$931M
$913K 0.06%
98,691
-95,908
-49% -$1.05M
SHLS icon
566
Shoals Technologies Group
SHLS
$1.25B
$913K 0.06%
92,199
-246,409
-73% -$2.24M
CHRW icon
567
C.H. Robinson
CHRW
$17.1B
$912K 0.06%
4,843
-717
-13% -$127K
GLP icon
568
Global Partners
GLP
$1.62B
$911K 0.06%
19,558
+10,730
+122% +$506K
ASTE icon
569
Astec Industries
ASTE
$935M
$910K 0.06%
14,872
+9,598
+182% +$530K
DAR icon
570
Darling Ingredients
DAR
$9.74B
$910K 0.06%
16,660
+11,703
+236% +$698K
SGHT icon
571
Sight Sciences
SGHT
$478M
$908K 0.06%
167,564
+77,651
+86% +$357K
BF.B icon
572
Brown-Forman Class B
BF.B
$11.9B
$905K 0.06%
+33,973
New +$915K
DOW icon
573
Dow Inc
DOW
$20.6B
$903K 0.06%
+33,018
New +$1.2M
VRDN icon
574
Viridian Therapeutics
VRDN
$2.34B
$903K 0.06%
+49,177
New +$792K
BCRX icon
575
BioCryst Pharmaceuticals
BCRX
$2.18B
$902K 0.06%
+90,210
New +$816K

Similar funds

GSA Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, GSA Capital Partners held 2,269 positions worth $1.59B, down 1.4% from $1.61B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.

GSA Capital Partners withdrew a net $179M in Q2 2026, closing 577 positions and reducing 559 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

Against the trend, GSA Capital Partners opened a new position in Northrop Grumman worth $5.25M.

  • GSA Capital Partners's largest Q2 2026 buy was Northrop Grumman: 10,314 shares worth $5.25M.
  • GSA Capital Partners added most to TJX Companies in Q2 2026, an estimated $5.66M increase.
  • GSA Capital Partners's biggest Q2 2026 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $20M.
  • GSA Capital Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $28M.
  • GSA Capital Partners's ten largest holdings make up 7.3% of its $1.59B portfolio in Q2 2026.
  • GSA Capital Partners opened 605 new positions and closed 577 in Q2 2026.
  • GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $1.59B.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.